Alteration of the lipid and apolipoprotein contents of lipoprotein(a) in haemodialysis patients

被引:4
|
作者
Hugue, V [1 ]
Kandoussi, M [1 ]
Parra, HJ [1 ]
Dracon, M [1 ]
Fruchart, JC [1 ]
Tacquet, A [1 ]
Cachera, C [1 ]
机构
[1] HOP CALMETTE,LAB RECH NEPHROL,LILLE,FRANCE
关键词
apo (a) phenotype; haemodialysis; immunoaffinity; Lp(a) apolipoproteins; Lp(a) lipids;
D O I
10.1093/oxfordjournals.ndt.a027406
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. To examine the possible alteration in Lp(a) composition, protein and lipid contents of Lp (a) were determined in 10 haemodialysis patients (HD) matched with 10 controls (C) for apo(a) phenotypes. Methods. All subjects (HD and C) had Lp(a) concentrations greater than 30 mg/dl (mean +/- SD : 82.3 +/- 41.4 vs 49.3 +/- 22.5 mg/dl), a concentration which has been determined to be associated with an elevated cardiovascular risk. Apo(a)-containing particles were isolated by immunoaffinity chromatography using a monoclonal anti-apo(a) antibody. Results. The molar concentrations of lipid and protein constituents of immunoaffinity isolated Lp(a) were expressed as number of moles per mole of apo(a). Lp(a) from HD patients were significantly richer in apo C111 (P<0.05) and triglycerides (TG) (P<0.05), compared to those of controls. Molar ratios of apo B, apo E, cholesterol and phospholipids per apo(a)-containing particles were in the same range in both groups. Conclusion. Lp(a) from HD patients is characterized by an elevated content in TG and apo C111 in comparison with those of controls. Further studies are needed to evaluate in HD patients the contribution of changes in Lp(a) composition towards the metabolism of these particles.
引用
收藏
页码:825 / 829
页数:5
相关论文
共 50 条
  • [21] Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders?
    Miremadi, S
    Sniderman, A
    Frohlich, J
    CLINICAL CHEMISTRY, 2002, 48 (03) : 484 - 488
  • [22] Study of serum leptin, lipid, lipoprotein and apolipoprotein levels as well as their correlation in gallbladder cholesterol patients
    Jin, Enyun
    Xu, Guoqiang
    Chen, Hongtan
    Qian, Jiajie
    Xu, Genyun
    Li, Youming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A439 - A440
  • [23] Influence of Apolipoprotein E genotype on lipid and lipoprotein levels in continuous ambulatory peritoneal dialysis patients
    Choi, KH
    Song, HY
    Shin, SK
    Noh, HJ
    Kang, SW
    Kim, JH
    Lee, HY
    Han, DS
    ADVANCES IN PERITONEAL DIALYSIS/1999, VOL 15, 1999, 15 : 243 - 246
  • [24] LIPID PATTERN, APOLIPOPROTEIN-A(1) AND APOLIPOPROTEIN-B AND LIPOPROTEIN(A) IN TYPE-1 DIABETIC-PATIENTS WITH MICROALBUMINURIA
    MAIOLI, M
    TONOLO, G
    ARCA, GM
    BRIZZI, P
    CHERCHI, GM
    CICCARESE, M
    PACIFICO, A
    REALDI, G
    ACTA DIABETOLOGICA, 1992, 29 (3-4) : 246 - 249
  • [25] Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate
    Marcil, VR
    Delvin, E
    Seidman, E
    Poitras, L
    Zoltowska, M
    Garofolo, C
    Levy, E
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2002, 283 (02): : G340 - G346
  • [26] Evaluation Of Lipid, Lipoprotein, And Apolipoprotein Analysis By Nuclear Magnetic Resonance
    Diffenderfer, Margaret R.
    Fernandes, Marianna
    He, Lihong
    Flowers, Sarah E.
    Schaefer, Ernst J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [27] Lipid, lipoprotein, and apolipoprotein profiles in active and sedentary men with tetraplegia
    Dallmeijer, AJ
    Hopman, MTE
    vanderWoude, LHV
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1997, 78 (11): : 1173 - 1176
  • [28] CURRENT LIPID, LIPOPROTEIN AND APOLIPOPROTEIN METHODS FOR ASSESSING RISK FOR CHD
    WARNICK, GR
    CLINICAL CHEMISTRY, 1986, 32 (06) : 1221 - 1221
  • [29] INTRAINDIVIDUAL FACTORS AFFECTING LIPID, LIPOPROTEIN AND APOLIPOPROTEIN MEASUREMENT - A REVIEW
    EVANS, K
    LAKER, MF
    ANNALS OF CLINICAL BIOCHEMISTRY, 1995, 32 : 261 - 280
  • [30] THE NEED FOR STANDARDIZATION OF LIPID, LIPOPROTEIN AND APOLIPOPROTEIN METHODS IN CLINICAL LABORATORIES
    COOPER, GR
    CLINICAL CHEMISTRY, 1986, 32 (06) : 1221 - 1221